GlobeNewswire
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
19/11/2026 -
Interim Results for the Third Quarter of 2026 - BioPorto reports continued NGAL growth and advances the U.S. Adult Validation Study
19/11/2026 -
Scancell Provides Corporate and Clinical Update
19/11/2026 -
DISCO Pharmaceuticals Announces Strategic Collaboration with AbbVie to Advance Next-Generation AND-Gated Bispecific Therapeutics for Solid Tumors
19/11/2026 -
AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads
19/11/2026 -
ALK presents new data at FAAM-EUROBAT-ISMA 2026: Data from a comparative study using adrenaline trainer devices suggests EURneffy® nasal adrenaline spray is more suitable for public places than an adrenaline auto-injector
19/11/2026 -
Asgard Therapeutics awarded €2.5m EIC Accelerator grant to advance lead program AT-108 toward the clinic
19/11/2026 -
Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term
19/11/2026 -
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
19/11/2026 -
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
19/11/2026 -
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering
19/11/2026 -
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
19/11/2026 -
InspireMD Announces First U.S. Commercial TCAR Procedures Using the FDA-Approved CGuard® Prime TransCarotid Stent System
18/11/2026 -
Cytek Biosciences to Participate in Upcoming Investor Conferences
18/11/2026 -
Onco360® Has Been Selected as a National Pharmacy Partner for PIMJETMI® (pimicotinib)
18/11/2026 -
His Choice Health Announces No Needle No Scalpel Vasectomy Clinic In Greenville, SC Opening January 7, 2027
18/11/2026 -
MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request
18/11/2026 -
Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program
18/11/2026 -
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
18/11/2026
Pages